ArrowKJ. The economics of moral hazard: further comment. Am Econ Rev. 1968;58(3):537-539.
3.
MartinABHartmanMLassmanDCatlinANational Health Expenditure Accounts Team. National health care spending in 2019: steady growth for the fourth consecutive year: study examines national health care spending for 2019. Health Aff. 2021;40(1):14-24.
4.
BrookRHKeelerEBLohrKN, et al. The Health Insurance Experiment: A Classic RAND Study Speaks to the Current Health Care Reform Debate. Santa Monica, CA: RAND Corporation; 2006.
5.
AgarwalRMazurenkoOMenachemiN. High-deductible health plans reduce health care cost and utilization, including use of needed preventive services. Health Aff. 2017;36(10):1762-1768.
6.
LeweyJGagneJJFranklinJLauffenburgerJCBrillGChoudhryNK. Impact of high deductible health plans on cardiovascular medication adherence and health disparities. Circ Cardiovasc Qual Outcomes. 2018;11(11):e004632.
7.
McClellanCFingarKRAliMMOlesiukWJMutterRGibsonTB. Price elasticity of demand for buprenorphine/naloxone prescriptions. J Subst Abuse Treat. 2019;106:4-11.
8.
WadheraRKMaddoxKEYehRWBhattDL. Public reporting of percutaneous coronary intervention outcomes: moving beyond the status quo. JAMA Cardiol. 2018;3(7):635-640.
9.
EibnerCButtorffCCefaluMKhodyakovDTaylorE.et al.The effect of Medicare Advantage Value-Based Insurance Design model test on utilization in 2017. Am J Health Promot. 2022; 36(4).
10.
Sherman B, Dankwa-Mullen I. For the commercially insured, equitable health benefits begin with equitable health insurance design. Am J Health Promot. 2022; 36(4).
11.
Udwin MR. Patient financial requirements from a physician's perspective: an interview with Michael Udwin. Am J Health Promot. 2022; 36(4).